Suppr超能文献

交联脱细胞真皮基质矫正创伤后眼球内陷的有效性。

Effectiveness of Cross-Linked Acellular Dermal Matrix to Correct Post-Traumatic Enophthalmos.

作者信息

Park Tae Hwan

机构信息

Department of Plastic and Reconstructive Surgery, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea.

出版信息

J Craniofac Surg. 2023;34(5):e449-e451. doi: 10.1097/SCS.0000000000009290. Epub 2023 Mar 20.

Abstract

BACKGROUND

The use of an acellular dermal matrix is rarely reported in orbital wall fracture reconstruction. This study aimed to share the author's experience with the cross-linked acellular dermal matrix as an allograft material for enophthalmos correction.

METHODS

In this retrospective study, the author evaluated the medical records and 3-dimensional facial computed tomography scans of patients with enophthalmos caused by neglected orbital fractures between May 2021 and June 2022. Facial computed tomography scans confirmed the clinical diagnosis of enophthalmos. A single surgeon performed all surgical operations. In all patients, the author accessed the orbital floor via subciliary incision while approaching the medial wall with a retrocaruncular incision. After fully exposing the lesion, the author used a 1.0-mm-thick cross-linked acellular dermal matrix (ADM) (MegaDerm; L&C Bio, South Korea). After trimming the cross-linked ADM to a proper size, the author implanted the ADM into the lesion.

RESULTS

During May 2021 and June 2022, 3 cases of enophthalmos were successfully corrected with cross-linked ADM at the author's hospital. All patients were improved clinically and radiologically.

CONCLUSION

This is the first study to show the effectiveness of cross-linked ADM for the correction of enophthalmos.

摘要

背景

脱细胞真皮基质在眶壁骨折重建中的应用鲜有报道。本研究旨在分享作者使用交联脱细胞真皮基质作为同种异体移植材料矫正眼球内陷的经验。

方法

在这项回顾性研究中,作者评估了2021年5月至2022年6月期间因被忽视的眼眶骨折导致眼球内陷患者的病历和面部三维计算机断层扫描。面部计算机断层扫描证实了眼球内陷的临床诊断。所有手术均由同一位外科医生进行。在所有患者中,作者通过睫毛下切口进入眶底,同时通过泪阜后切口进入内侧壁。充分暴露病变后,作者使用了1.0毫米厚的交联脱细胞真皮基质(ADM)(MegaDerm;韩国L&C生物公司)。将交联ADM修剪至合适大小后,作者将其植入病变部位。

结果

2021年5月至2022年6月期间,作者所在医院3例眼球内陷患者使用交联ADM成功矫正。所有患者在临床和影像学上均有改善。

结论

这是第一项显示交联ADM矫正眼球内陷有效性的研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验